Doctor profile · Federal record
Dr. Vipul Joshi, MD
Specialist (CMS: Rheumatology) · Brandon, FL
- NPI 1003868993
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1355 Providence RD
Brandon, FL 335114885
(813) 651-4441
fax (813) 661-3374 - Mailing address
-
Po Box 1192
Brandon, FL 335091192
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- October 14, 2011
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Florida #ME87414
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1003868993. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
629,428
Distinct HCPCS
10
Medicare allowed
$6,975,116
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 340,000 | 99 | $5 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 101,220 | 92 | $10 | |
J3262 |
Injection, tocilizumab, 1 mg | 64,043 | 24 | $6 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 40,500 | 66 | $42 | |
J0897 |
Injection, denosumab, 1 mg | 32,700 | 343 | $23 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 28,850 | 37 | $13 | |
J9312 |
Injection, rituximab, 10 mg | 3,900 | 14 | $80 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 3,751 | 13 | $33 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 2,727 | 466 | $69 | |
86235 |
Measurement of antibody for assessment of autoimmune disorder, any method | 2,541 | 319 | $17 |
In context: peer comparison
Among 3 peers in Brandon Specialist, average services per provider: 7,464. This provider delivers 84× the peer median.Open Payments
Industry payments received
All-time total
$3,740
Transactions
213
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 60 | $1,102.76 | |
| Ucb, INC. | 39 | $430.37 | |
| Abbvie INC. | 16 | $385.80 | |
| Janssen Biotech, INC. | 16 | $311.49 | |
| AstraZeneca Pharmaceuticals Lp | 14 | $303.48 | |
| Novartis Pharmaceuticals Corporation | 17 | $191.86 | |
| E.R. Squibb & Sons, L.L.C. | 11 | $187.49 | |
| Pfizer INC. | 11 | $154.61 | |
| Radius Health, INC. | 8 | $132.55 | |
| Mallinckrodt Hospital Products INC. | 5 | $111.69 | |
| GlaxoSmithKline, LLC. | 6 | $88.41 | |
| Genzyme Corporation | 3 | $76.20 | |
| Lilly USA, LLC | 3 | $60.18 | |
| Genentech USA, INC. | 2 | $44.99 | |
| Scilex Pharmaceuticals INC. | 2 | $42.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
440
Patients
110
Total drug cost
$10,456
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tramadol Hcl | Generic | 306 | 67 | $2,430 |
| Pregabalin | Generic | 109 | 31 | $7,909 |
| Methylprednisolone | Generic | 13 | 12 | $90 |
| Clonazepam | Generic | 12 | 0 | $26 |
Frequently asked questions
What is Dr. Vipul Joshi's medical specialty?
Dr. Vipul Joshi practices Specialist in Brandon, FL.
Where does Dr. Vipul Joshi practice?
Dr. Vipul Joshi practices at 1355 Providence RD, Brandon, FL 335114885. Office phone: 8136514441.
What is Dr. Vipul Joshi's NPI?
Dr. Vipul Joshi's National Provider Identifier (NPI) is 1003868993, issued by NPPES.
Does Dr. Vipul Joshi accept Medicare assignment?
Yes. Dr. Vipul Joshi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Vipul Joshi commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, tocilizumab, 1 mg (HCPCS J3262). Source: CMS Medicare Physician & Other Practitioners file.